BCC Identity-01.png
Brain Cancer Canada, a leading advocate in the fight against brain cancer, is proud to award a $100,000 research grant to one of Canada’s top neuropathologists to support research on one of the deadliest pediatric brain cancers
03 déc. 2024 10h00 HE | Brain Cancer Canada
TORONTO, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Brain Cancer Canada is pleased to announce a $100,000 pediatric research grant awarded to Dr. Cynthia Hawkins, neuropathologist-scientist, and her team at...
Bourse Biocodex Microbiota Fondation
La Fondation du Microbiote de Biocodex invite les universitaires et scientifiques canadiens à soumettre leur candidature pour une bourse de recherche de 25 000 €. L’objectif est de faire progresser l’étude du rôle du microbiote sur la santé et les maladies
30 sept. 2024 16h09 HE | Biocodex Canada
MONTRÉAL, 30 sept. 2024 (GLOBE NEWSWIRE) -- La Fondation du Microbiote de Biocodex, une organisation fondée par Biocodex et ayant pour vocation d’inspirer des projets scientifiques explorant le...
Biocodex Microbiota Fondation Grant
Biocodex Microbiota Foundation Invites Canadian Academics and Scientists to Apply for €25,000 Research Grant to Advance Microbiota’s role Study in health and diseases
30 sept. 2024 16h09 HE | Biocodex Canada
Biocodex Microbiota Foundation offers a €25,000 Research Grant to Advance Microbiota’s role Study in health and diseases.
Muscular Dystrophy Association Research Grant for the HEALEY ALS Platform Trial
MDA Awards $500,000 Grant to Accelerate ALS Research Through the HEALEY ALS Platform Trial at Massachusetts General Hospital
19 sept. 2024 09h00 HE | Muscular Dystrophy Association
New York, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The Muscular Dystrophy Association (MDA) is proud to announce a new clinical research grant of $500,000 over three years, awarded to Sabrina Paganoni,...
Grant 2024 Poster_FR
La Fondation du Microbiote de Biocodex invite les universitaires et scientifiques canadiens à soumettre leur candidature pour une bourse de recherche de 25 000 €. L’objectif est de faire progresser l’étude du rôle du microbiote sur la santé et les maladies
30 avr. 2024 10h30 HE | Biocodex Canada
MONTRÉAL, 30 avr. 2024 (GLOBE NEWSWIRE) -- La Fondation du Microbiote de Biocodex, une organisation fondée par Biocodex et ayant pour vocation d’inspirer des projets scientifiques explorant le...
Grant 2024 Poster_EN
Biocodex Microbiota Foundation Invites Canadian Academics and Scientists to Apply for €25,000 Research Grant to Advance Microbiota’s role Study in health and diseases
30 avr. 2024 10h30 HE | Biocodex Canada
Bourse de recherche de 25 000$ de la Fondation du Microbiote de Biocodex invite les universitaires et scientifiques canadiens.
ISHLT Supports Resea
ISHLT Supports Research Funding for Advanced Heart and Lung Disease: Applications Open Now Chicago, IL, Nov. 07, 2023 (GLOBE NEWSWIRE) -- The International Society for Heart and Lung Transplantation (ISHLT) is now accepting applications for three research grants to be awarded during the...
National Research Grant Canada 2023
The Biocodex Microbiota Foundation calls for Canadian proposals to study the microbiome’s role in health and diseases
31 juil. 2023 16h20 HE | Biocodex Canada
The Biocodex Microbiota Foundation is looking for academics and scientists in Canada to apply for a €25,000 research grant aimed at helping advance the study of the gut microbiome MONTREAL, July 31,...
Collaborative Research Grant for Duchenne Muscular Dystrophy Announced
CureDuchenne, Muscular Dystrophy Association, and Parent Project Muscular Dystrophy Announce Collaborative Project to Focus on Re-Dosing Gene Therapy in Duchenne Muscular Dystrophy
15 juin 2023 14h43 HE | Muscular Dystrophy Association
New York, June 15, 2023 (GLOBE NEWSWIRE) -- June 15, 2023 -- CureDuchenne, Muscular Dystrophy Association (MDA), and Parent Project Muscular Dystrophy (PPMD), today announced a collaborative...
emerge.png
Emergent BioSolutions Receives Department of Defense Award to Evaluate Chikungunya Vaccine Candidate in Post-Approval Field Efficacy Study Using Model-Guided Approach
14 nov. 2022 06h30 HE | Emergent BioSolutions
GAITHERSBURG, Md., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today a research award by the U.S. Department of Defense (DoD) Congressionally Directed Medical...